<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Hydralazine" /><meta name="IX" content="Hydralazine" /><title>Hydralazine: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP1049-hydralazine-non-proprietary.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP1049-hydralazine-non-proprietary.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP1049-hydralazine-non-proprietary.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 07 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP747-cardiovascular-system.htm">2 Cardiovascular system</a> &gt; <a href="PHP1034-hypertension-and-heart-failure.htm">2.5 Hypertension and heart failure</a> &gt; <a href="PHP1040-vasodilator-antihypertensive-drugs.htm">2.5.1 Vasodilator antihypertensive drugs</a> &gt; <a href="PHP1048-hydralazine-hydrochloride.htm">HYDRALAZINE HYDROCHLORIDE</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP1046-diazoxide.htm" title="Previous: DIAZOXIDE">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP1052-iloprost.htm" title="Next: ILOPROST">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a382246.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Hydralazine Hydrochloride</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Cardiovascular Drugs 24:00 &gt; Hypotensive Agents 24:08 &gt; Direct Vasodilators 24:08.20</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/21149-g.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Hydralazine</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: H &gt; Interactions of Hydralazine</p></div></li></ul><ul><li><h3>British National Formulary (4)</h3></li><li><a href="PHP1040-vasodilator-antihypertensive-drugs.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">2.5.1 Vasodilator antihypertensive drugs</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.5 Hypertension and heart failure</p></div></li><li><a href="PHP1048-hydralazine-hydrochloride.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">HYDRALAZINE HYDROCHLORIDE</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.5 Hypertension and heart failure &gt; 2.5.1 Vasodilator antihypertensive drugs</p></div></li><li><a href="PHP1050-apresoline.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Apresoline®</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.5 Hypertension and heart failure &gt; 2.5.1 Vasodilator antihypertensive drugs &gt; HYDRALAZINE HYDROCHLORIDE</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22hydralazine+hydrochloride%22%22hydralazine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (4)</a></li></ul><ul><li><h3>BNF for Children (4)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP11531-vasodilator-antihypertensives.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">2.5.1.1 Vasodilator antihypertensives</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 2 Cardiovascular system &gt; 2.5 Hypertension &gt; 2.5.1 Vasodilator antihypertensive drugs and pulmonary hypertension</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP11536-hydralazine-hydrochloride.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">HYDRALAZINE HYDROCHLORIDE</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 2 Cardiovascular system &gt; 2.5 Hypertension &gt; 2.5.1 Vasodilator antihypertensive drugs and pulmonary hypertension &gt; 2.5.1.1 Vasodilator antihypertensives</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP11537-hydralazine-non-proprietary.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Hydralazine</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 2 Cardiovascular system &gt; 2.5 Hypertension &gt; 2.5.1 Vasodilator antihypertensive drugs and pulmonary hypertension &gt; 2.5.1.1 Vasodilator antihypertensives &gt; HYDRALAZINE HYDROCHLORIDE</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22hydralazine+hydrochloride%22%22hydralazine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (4)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK0844.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Hydralazine</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; H</p></div></li></ul><ul><li><h3>Dietary Supplements (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/diet/2010/c97.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Vitamin B6</a><div class="breadcrumb"><p><strong>Dietary Supplements</strong> &gt; Monographs &gt; V</p></div></li><li><a href="http://www.medicinescomplete.com/mc/diet/2010/a02.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Appendix 2: Drug and supplement interactions</a><div class="breadcrumb"><p><strong>Dietary Supplements</strong> &gt; Monographs &gt; Appendices</p></div></li></ul><ul><li><h3>Handbook on Injectable Drugs</h3></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a582094.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Hydralazine Hydrochloride</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; H</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0008s0026.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Hydralazine</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; H</p></div></li></ul><ul><li><h3>Injectable Drugs Guide</h3></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/H07-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Hydralazine hydrochloride</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; H</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/878-f.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Hydralazine Hydrochloride</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Cardiovascular Drugs &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/04763.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Hydralazine</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; H &gt; HY</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-H23.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Hydralazine Hydrochloride</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; H</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E2E3E0R0D1136.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Hydralazine</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; H</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c180.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Hydralazine hydrochloride</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; H</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>HYDRALAZINE HYDROCHLORIDE</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int763-hydralazine.htm">Hydralazine</a>).</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">moderate to severe hypertension (adjunct); heart failure (with long-acting nitrate, but see <a title=" Drugs affecting the renin-angiotensin system" href="PHP1122-drugs-affecting-the-renin-angiotensin-system.htm">section 2.5.5</a>); <a title="BNF:target-block: Accelerated or very severe hypertension" href="PHP1034-hypertension-and-heart-failure.htm#PHP1039">hypertensive emergencies</a> (including during <a title="BNF:target-block: Hypertension in pregnancy" href="PHP1034-hypertension-and-heart-failure.htm#PHP1038">pregnancy</a>) (see <a title="BNF:target-block: Accelerated or very severe hypertension" href="PHP1034-hypertension-and-heart-failure.htm#PHP1039">section 2.5</a>)</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">coronary artery disease (may provoke angina, avoid after myocardial infarction until stabilised), cerebrovascular disease; occasionally blood pressure reduction too rapid even with low parenteral doses; manufacturer advises test for antinuclear factor and for proteinuria every 6 months and check acetylator status before increasing dose above 100 mg daily, but evidence of clinical value unsatisfactory; <strong>interactions:</strong> Appendix 1 (hydralazine)</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Contra-indications </h2> <p class="cT">idiopathic systemic lupus erythematosus, severe tachycardia, high output heart failure, myocardial insufficiency due to mechanical obstruction, cor pulmonale, dissecting aortic aneurysm; acute porphyria (<a title=" Acute porphyrias" href="PHP6363-acute-porphyrias.htm">section 9.8.2</a>)</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Hepatic impairment </h2> <p class="cT">reduce dose</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Renal impairment </h2> <p class="cT">reduce dose if eGFR less than 30 mL/minute/1.73 m<sup>2</sup></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">neonatal thrombocytopenia reported, but risk should be balanced against risk of uncontrolled maternal hypertension; manufacturer advises avoid before third trimester</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">present in milk but not known to be harmful; monitor infant</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">tachycardia, palpitation, flushing, hypotension, fluid retention, gastro-intestinal disturbances; headache, dizziness; systemic lupus erythematosus-like syndrome after long-term therapy with over 100 mg daily (or less in women and in slow acetylator individuals) (see also notes above); rarely rashes, fever, peripheral neuritis, polyneuritis, paraesthesia, arthralgia, myalgia, increased lacrimation, nasal congestion, dyspnoea, agitation, anxiety, anorexia; blood disorders (including leucopenia, thrombocytopenia, haemolytic anaemia), abnormal liver function, jaundice, raised plasma creatinine, proteinuria and haematuria reported</p></div> </div> <div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul> <li><p><span class="cK">By mouth</span>, hypertension, 25 mg twice daily, increased to usual max. 50 mg twice daily (see notes above)</p> <p>Heart failure (initiated in hospital) 25 mg 3–4 times daily, increased every 2 days if necessary; usual maintenance dose 50–75 mg 4 times daily</p> </li> <li><p><span class="cK">By slow intravenous injection</span>, hypertensive emergencies and hypertension with renal complications, 5–10 mg diluted with 10 mL sodium chloride 0.9%; may be repeated after 20–30 minutes (see Cautions)</p> </li> <li><p><span class="cK">By intravenous infusion</span>, hypertensive emergencies and hypertension with renal complications, initially 200–300 micrograms/minute; maintenance usually 50–150 micrograms/minute</p> </li> </ul></div></div> </div><div id="pS"><p>Sub-sections</p><div id="PHP1049-hydralazine-non-proprietary" style="margin: 0 0 0 20px;"><h1 class="title">Hydralazine <span>(Non-proprietary)</span><span> <img src="images/pom_l.png" alt="Prescription only medicine" /></span></h1><div class="cU"><p><strong>Tablets</strong>, hydralazine hydrochloride 25 mg, net price 56 = £7.54; 50 mg, 56 = £15.18</p></div></div><ul class="jT"><li><a href="PHP1050-apresoline.htm#PHP1050-apresoline" title="Apresoline®">Apresoline®</a></li><li><a href="PHP1051-hydralazine-hydrochloride-formulations-unlicensed.htm#PHP1051-hydralazine-hydrochloride-formulations-unlicensed" title="Hydralazine hydrochloride formulations [unlicensed]">Hydralazine hydrochloride formulations [unlicensed]</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP1046-diazoxide.htm">Previous: DIAZOXIDE</a> | <a class="top" href="PHP1049-hydralazine-non-proprietary.htm#">Top</a> | <a accesskey="]" href="PHP1052-iloprost.htm">Next: ILOPROST</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>